Despite a share price rise, Trinity Biotech's P/S remains lo...
Despite a share price rise, Trinity Biotech's P/S remains low compared to industry medians. Given recent revenue trends, there may not be substantial share price movement without major changes to revenue trends.
There's No Escaping Trinity Biotech Plc's (NASDAQ:TRIB) Muted Revenues Despite A 26% Share Price Rise
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment